Company page

Nervgen Pharma Corp.

Nervgen Pharma Corp. is a public company traded under the ticker NGEN in the American market, with a market capitalization of approximately $180.8 million. The company focuses on developing innovative therapies for nerve damage and neurodegenerative diseases. Nervgen aims to address significant unmet medical needs through its research and development efforts.